Evozyne
PrivateLast Round
Series B
Sep 27, 2023
Total Funding Raised
$149.18M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Evozyne is a biotechnology company that operates a data-driven molecular engineering platform to develop innovative proteins with enhanced functionalities tailored to meet specific health challenges.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evozyne Comparables
Compare Evozyne with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nabla | 88% | |
| AI Proteins | 86% | |
| Profluent Bio | 85% |
Evozyne Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 27, 2023 | ||||
| Series A | Apr 21, 2021 | ||||
| Seed | Apr 27, 2020 |
Key People
Founding team and executive leadership
Evozyne Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fidelity Management & Research Company | Series A, Series B |
| OrbiMed | Series B |
| Paragon Biosciences | Seed, Series B, Series A |
| NVentures | Series B |
| Valor Equity Partners | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 87% MoM, from 2.7K to 5K.
- Sep 27, 2023
$81M round led by Fidelity Management & Research Company and OrbiMed.
Evozyne Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Evozyne's valuation, stock price, and market status.
Is Evozyne a public or private company?
Evozyne is a private company.
What is the current stock price of Evozyne?
Evozyne is a private company with no public stock price. No recent secondary market data is available.
How much is Evozyne worth (valuation)?
Valuation information for Evozyne is not publicly available.
Can I buy Evozyne stock?
Evozyne shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Evozyne's last funding round?
Evozyne's most recent funding round was Series B on September 27, 2023.
Who are the main investors in Evozyne?
Key investors in Evozyne include Fidelity Management & Research Company, OrbiMed.
Will Evozyne IPO soon?
No public IPO plans have been announced for Evozyne.
How can I track Evozyne secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Evozyne's secondary market activity and sign up for updates.